| Life beyond a diagnosis of glioblastoma: a systematic review of the literature L Gately, SA McLachlan, A Dowling, J Philip Journal of cáncer Survivorship 11, 447-452, 2017 | 97 | 2017 |
| Age alone is not a predictor for survival in glioblastoma L Gately, A Collins, M Murphy, A Dowling Journal of neuro-oncology 129, 479-485, 2016 | 53 | 2016 |
| Long-term survivors of glioblastoma: a closer look L Gately, SA McLachlan, J Philip, J Ruben, A Dowling Journal of neuro-oncology 136, 155-162, 2018 | 44 | 2018 |
| Re‐inventing the randomized controlled trial in medical oncology: The registry‐based trial S Foroughi, H Wong, L Gately, M Lee, K Simons, J Tie, AW Burgess, ... Asia‐Pacific Journal of Clinical Oncology 14 (6), 365-373, 2018 | 32 | 2018 |
| Molecular profile of long-term survivors of glioblastoma: A scoping review of the literature L Gately, SA McLachlan, J Philip, V Rathi, A Dowling Journal of Clinical Neuroscience 68, 1-8, 2019 | 19 | 2019 |
| Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond H Wong, M Christie, L Gately, J Tie, B Lee, C Semira, SW Lok, R Wong, ... Future Oncology 14 (26), 2725-2739, 2018 | 17 | 2018 |
| Leveraging comprehensive cancer registry data to enable a broad range of research, audit and patient support activities B Lee, L Gately, SW Lok, B Tran, M Lee, R Wong, B Markman, K Dunn, ... Cancers 14 (17), 4131, 2022 | 11 | 2022 |
| A polygenic risk score predicts incident prostate cancer risk in older men but does not select for clinically significant disease A Bakshi, M Riaz, SG Orchard, PR Carr, AD Joshi, Y Cao, R Rebello, ... Cancers 13 (22), 5815, 2021 | 10 | 2021 |
| Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer M Loft, SW Lok, R De Boer, L Malik, S Greenberg, B Yeo, A Anton, ... Breast Cancer Research and Treatment 198 (1), 67-74, 2023 | 8 | 2023 |
| Stage dependent recurrence patterns and post-recurrence outcomes in non-metastatic colon cancer L Gately, A Jalali, C Semira, I Faragher, M Croxford, S Ananda, ... Acta Oncologica 60 (9), 1106-1113, 2021 | 8 | 2021 |
| Surviving glioblastoma and a sense of disconnection L Gately, SA McLachlan, A Dowling, J Philip Journal of Clinical Neuroscience 81, 284-289, 2020 | 7 | 2020 |
| Registry-based randomized clinical trials as a method to improve cancer care in Australia S Foroughi, H Wong, L Gately, M Lee, K Simons, J Tie, AW Burgess, ... Asia Pac J Clin Oncol 15, 188-189, 2019 | 7 | 2019 |
| Direct access colonoscopy: impact of intervention on time to colorectal cancer diagnosis and treatment in North West Tasmania P Allen, L Gately, P Banks, AAYS Lee, G Hamilton, L Tan, S Sim Internal medicine journal 47 (10), 1129-1135, 2017 | 7 | 2017 |
| Drinking from the firehose–A clinician's perspective on the challenges of delivering biomarker-driven care in routine practice C Dunn, L Gately, P Gibbs European Journal of Cancer 157, 301-305, 2021 | 6 | 2021 |
| Genomic risk prediction for breast cancer in older women P Lacaze, A Bakshi, M Riaz, SG Orchard, J Tiller, JT Neumann, PR Carr, ... Cancers 13 (14), 3533, 2021 | 6 | 2021 |
| Emerging strategies in the initial management of locally advanced rectal cancer L Gately, HL Wong, J Tie, R Wong, M Lee, B Lee, A Jalali, P Gibbs Future Oncology 15 (25), 2955-2965, 2019 | 5 | 2019 |
| Early death after chemotherapy as a quality indicator—is it time to bench the benchmark? C Dunn, L Gately, P Gibbs JAMA oncology 8 (11), 1559-1560, 2022 | 3 | 2022 |
| Beyond standard data collection–the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry) L Gately, K Drummond, M Rosenthal, R Harrup, A Dowling, A Gogos, ... BMC cancer 22 (1), 604, 2022 | 3 | 2022 |
| A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma L Gately, C Mesía, JM Sepúlveda, S Del Barco, E Pineda, R Gironés, ... Journal of Neuro-Oncology 166 (3), 407-415, 2024 | 2 | 2024 |
| Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer A Jalali, G Gard, S Banks, C Dunn, HL Wong, R Wong, M Lee, L Gately, ... Current Problems in Cancer 46 (2), 100793, 2022 | 2 | 2022 |
